| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/26/2002 | US20020197237 Adeno-associated virus vectors |
| 12/26/2002 | US20020197231 Relaxing gelling bath compositions |
| 12/26/2002 | US20020197220 Composition comprising at least one liquid fatty phase structured by at least one semi-crystalline polymer |
| 12/26/2002 | US20020197216 Cross-regulin composition of turmeric-derived tetrahydrocurcuminoids for skin lightening and protection against UVB rays |
| 12/26/2002 | CA2391588A1 Cosmetic or dermatological composition including an association between an elastase-inhibiting compound of the n-acylamino amides family and at least one anti-inflammatory compound |
| 12/26/2002 | CA2391580A1 Cosmetic or dermatological composition including an association between an elastase-inhibiting compound of the n-acylamino amides family and at least one antifungal agent or at least one antibacterial agent |
| 12/25/2002 | CN1387576A Sequence-specific DNA recombination in ekaryotic cells |
| 12/25/2002 | CN1387575A Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 12/25/2002 | CN1387570A Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for treatment of obesity |
| 12/25/2002 | CN1387567A Conjugates between peptides and nucleic acid analog, such as PNA, LNA or morpholino |
| 12/25/2002 | CN1387537A Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 12/25/2002 | CN1387531A Pyrazolo [4,3-d] pyrimidine derivs. |
| 12/25/2002 | CN1387530A Imidazopyridine derivs. used as phosphodiesterase VII inhibitors |
| 12/25/2002 | CN1387529A N-substd. carbamoyloxyalkyl-azolium derivs. |
| 12/25/2002 | CN1387528A Heterocyclic substd, pyrazolones |
| 12/25/2002 | CN1387527A Qinazoline derivs. as VEGF inhibitors |
| 12/25/2002 | CN1387526A Cyclopropanes as CGRP antagonists, medicaments contg. said compounds and method for production thereof |
| 12/25/2002 | CN1387522A Process for preparing epoxy compounds, aromatic compositions contg. same, and drinks, perfmes, cosmetics, cigarettes, and tobaccos contg. said compositions |
| 12/25/2002 | CN1387518A Heterocyclic substd, diphenyl leukotriene antagonists |
| 12/25/2002 | CN1387517A 5-aryl-1H-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions contg. them |
| 12/25/2002 | CN1387516A Substd. 5-benzyl-2,4-diaminopyrimidines |
| 12/25/2002 | CN1387514A Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 12/25/2002 | CN1387513A Positive modulators of nicotinic receptor agonists |
| 12/25/2002 | CN1387512A Positive modulators for nicotinic receptor agonists |
| 12/25/2002 | CN1387509A Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 12/25/2002 | CN1387508A N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them |
| 12/25/2002 | CN1387507A Diaryl-enynes |
| 12/25/2002 | CN1387505A Compositions contg. hydroxyeicosatetraenoic acid derivs, and methods of use in treating dry eye disorders |
| 12/25/2002 | CN1387504A Omega-chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for treatment of dry eye |
| 12/25/2002 | CN1387503A Hydroxyeicosatetraenoate salts, composition and method of use in treating dry eye disorders |
| 12/25/2002 | CN1387502A 15-hydroxyeicosatetraenoic acid-related compounds and methods of use |
| 12/25/2002 | CN1387450A Use of dopamine-D3 receptor agonists for therapy of salt-dependent hypertension |
| 12/25/2002 | CN1387441A Use of nitric oxide for treatment of airway constriction |
| 12/25/2002 | CN1387439A Treatment of diabetic nephropathy and microalbuminuria |
| 12/25/2002 | CN1387438A 联合化学疗法 Combined chemotherapy |
| 12/25/2002 | CN1387437A 治疗用途 Therapeutic use |
| 12/25/2002 | CN1387436A Preventive and therapeutic agents for eye diseases |
| 12/25/2002 | CN1387435A Lipoxin A4 and its analogs for treatment of dry eye |
| 12/25/2002 | CN1387434A Synergistic combinations of NK1 receptor antagonist and GABA structural analog |
| 12/25/2002 | CN1387433A Method for administering phosphodiesterase 4 inhibitor |
| 12/25/2002 | CN1387432A Methods of sing rapid-onset selective serotonin reuptake inhibitors for treating sexual dysfnction |
| 12/25/2002 | CN1387431A Combination comprising beta 2 adranoreceptor agonist and lenkotriene receptor antagonist |
| 12/25/2002 | CN1387430A Liver selective therapy |
| 12/25/2002 | CN1387404A Method and compositions for treating pulmonary diseases |
| 12/25/2002 | CN1386744A Process for extracting triterpenic acid from gleditschia, and medical use and Chinese medicine of triterpenic acid |
| 12/25/2002 | CN1386742A Flavone derivatives and preparing process and use thereof |
| 12/25/2002 | CN1386737A Antifibrosis pyridinone medicine and its prepaing process |
| 12/25/2002 | CN1386532A Exterior-applied antalgic medicine and its preparing process |
| 12/25/2002 | CN1386513A Ointment for treating burn and scald and its preparing process |
| 12/25/2002 | CN1386510A Composition of suppressing infection, and veberage and food contg. same |
| 12/25/2002 | CN1386508A Artificial tear containing chitosan and its preparing process |
| 12/25/2002 | CN1386507A Compound antiparasitic medicine for fish or full-value feed containing antiparasitic medicine |
| 12/25/2002 | CN1386506A Sulfamine ointment |
| 12/25/2002 | CN1386505A Application of Na-ion channel blocker and opium antalgesic in preparing synergic antalgic medicine for mammal |
| 12/25/2002 | CN1386504A Combined therapy for melancholia and anxiety |
| 12/25/2002 | CN1386503A Combined therapy for treating alcoholism and addiction of alcohol |
| 12/25/2002 | CN1386502A Application of niflumic acid in preventing and treating arrhythmia |
| 12/25/2002 | CN1386501A Omega-3 fatty acid capsule |
| 12/25/2002 | CN1386500A Application of diphenylvinyl phenol glucoside compounds in preparing hypoglycemic medicine |
| 12/25/2002 | CN1386499A Application of diphenylvinyl phenol glucosides in preparing hypolipemic medicine |
| 12/25/2002 | CN1386497A Alpha-linolenic acid microcapsule and its preparing process |
| 12/25/2002 | CN1386493A Cosmetics or medical preparation contg. alkenylaminotriazine as sunlight ageing-proof agent, and alkenylaminotriazine |
| 12/25/2002 | CN1386417A Antiparasitic mixture and pre-mixture containing cyromazine and macrolide insect repellents |
| 12/25/2002 | CN1097056C Counterpart of camptothecin, their application as medicine and pharmaceutical compositions contg. them |
| 12/25/2002 | CN1097055C Taxena derivs., preparation thereof formulation contg. them |
| 12/25/2002 | CN1097054C Tricyclic pyrazole derivs. and composition |
| 12/25/2002 | CN1097053C 1,2,3,4-tetrahydro-benzofuro [3,2-c] pyridine derivs., preparing method and use thereof |
| 12/25/2002 | CN1097052C Process for production of amidinoindole derivs, and salts thereof |
| 12/25/2002 | CN1097051C N-heteroaryl-pyridinesulfonamide derivs. and their use as endotheliin antagonists |
| 12/25/2002 | CN1097050C Substd 2,4-imidazolidinedione compounds and pharmaceutical active ingredients |
| 12/25/2002 | CN1097049C Processes for preparing intermediate product used in method of diastereoselective synthesis of nucleosides |
| 12/25/2002 | CN1096867C Antiulcer agent and adhesion inhibitor for helicobacter pyroli |
| 12/25/2002 | CN1096862C Controlled-release dosage form of azithromycin |
| 12/25/2002 | CN1096861C Method of treating androgenic alopecia with 5-alpha reductase inhibitors |
| 12/25/2002 | CN1096860C Topical ketoconazole compositions |
| 12/25/2002 | CN1096859C Xanthine deriv. |
| 12/25/2002 | CN1096858C Gepirone dosage form |
| 12/25/2002 | CN1096857C Iontophoretic delivery of antimigraine drug |
| 12/25/2002 | CN1096856C Method for topical treatment of scar tissue and related tissue reaction to trauma |
| 12/25/2002 | CN1096855C Composition produced by treatment and induction of nitrogen mono oxide synthase expressed matter, and use thereof |
| 12/25/2002 | CN1096854C GABA-ergic modulation of eye growth |
| 12/25/2002 | CN1096853C Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof |
| 12/25/2002 | CN1096843C Cosmatic and/or dermal composition contg. salicyclic acid |
| 12/25/2002 | CN1096834C Flavonol contg. food supplements |
| 12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/24/2002 | US6498274 Amide derivatives for the treatment of diseases mediated by cytokines |
| 12/24/2002 | US6498273 For imaging organs or structures including blood vessels, a thrombus within a vessel, heart, brain, kidney, liver, lungs, spleen, etc., meidcal diagnosis |
| 12/24/2002 | US6498257 2,3-olefinic epothilone derivatives |
| 12/24/2002 | US6498255 Cholinesterase inhibitors; cognition activators; alzheimer's disease; e.g., 3-(2-(1-(phenylmethyl)-4-piperidinyl)ethyl)-1,2-benzisoxazole |
| 12/24/2002 | US6498254 Antiretroviral compounds and compositions |
| 12/24/2002 | US6498252 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 12/24/2002 | US6498251 Tetrahydrobenzindole derivatives |
| 12/24/2002 | US6498248 Low temperature non-crystallizing liquid xylitol compositions and co-hydrogenation processes for making same |
| 12/24/2002 | US6498247 Alkali or alkaline earth metal of n-butyric acid for treatment of cognitive and emotional conditions |
| 12/24/2002 | US6498241 2-deoxy-isoguanosines isosteric analogues and isoguanosine derivatives as well as their synthesis |
| 12/24/2002 | US6498195 For prophylaxis and therpy of cancer |
| 12/24/2002 | US6498193 Treatment for complications of type 2 diabetes |
| 12/24/2002 | US6498192 Administering a polyamine depleting agent, such as difluoro-methylornithine; ornithine decarboxylase inhibitors; prefer-entially killing cancer cells versus normal cells during radiation therapy |
| 12/24/2002 | US6498191 For treatment of alzheimer's disease, diabetes mellitus, parkinson's disease, neuronal and cardiac ischemia, huntington's disease, stroke |
| 12/24/2002 | US6498190 Bicyclic amino derivatives and PGD2 antagonist containing the same |